期刊文献+

子宫内膜轻度不典型增生药物治疗的效果探讨 被引量:8

Comparision of the effect of three conservative treatments on mild atypical endometrial hyperplasia
原文传递
导出
摘要 目的比较醋酸戈舍瑞林、醋酸甲羟孕酮片以及复方醋酸棉酚片3种药物治疗子宫内膜轻度不典型增生的临床疗效。方法选择2008年1月至2013年12月新疆医科大学第一附属医院收治的未绝经及要求保守治疗的子宫内膜轻度不典型增生患者73例,根据治疗方法的不同,将研究对象分为三组:A组:醋酸戈舍瑞林组25例;B组:醋酸甲羟孕酮组24例;C组:醋酸棉酚组24例。所有患者用药疗程为3个月,治疗后均行宫腔镜检查+全面诊刮。对比3种药物治疗3个月后及随访1年后的疗效。结果 1 A组、B组和C组三组完全缓解率分别为:100.00%(25/25),70.83%(17/24)和83.33%(20/24)。治疗3个月后三组疗效差异有统计学意义(P=0.019)。A组和B组差异有统计学意义(P=0.004),A组完全缓解率高于B组;2随访1年后A组、B组和C组三组完全缓解率分别为:72.00%(18/25),64.71%(11/17)和100.00%(20/20)。3种治疗方法的疗效差异有统计学意义(P=0.021)。A组和C组、B组和C组之间差异有统计学意义(P=0.011;P=0.004),C组的完全缓解率高于A组及B组;3随访1年中3种治疗方法疾病复发率:A组20.00%(5/25)、B组0%(0/17)和C组0%(0/20)。A组的疾病复发率高于另外两组。结论 1复方醋酸棉酚片可能成为年龄≥45岁的子宫内膜轻度不典型增生女性的一个较好的保守治疗方法;2 GnRH-a治疗子宫内膜轻度不典型增生短期效果较好,但有较高的疾病复发率。 Objective To compare the effect of Goserelin acetate,Medroxyprogesterone acetate and Gossypol acetic acid on the treatment of mild atypical endometrial hyperplasia.Methods A study was carry out on 73 cases with atypical endometrial hyperplasia patients who admitted to the First Affiliated Hospital of Xinjiang Medical University from Jan.2008 to Jun.2013.According to the different treatment methods,73 cases were divided into three groups:Group A:Goserelin acetate group,25cases;Group B:medroxyprogesterone acetate group 24cases;Group C:Gossypol acetic acid group,24 cases.After three months treatment,73 cases were examined by hysteroscopy and histopathological diognosis was made.All cases were under follow-up for one year and the therapeutic effects was compared.Results 1 The complete remission rates of the three groups were:100.00%(25/25),70.83%(17/24)and 83.33%(20/24),respectively(P=0.019).The complete remission rates of Group A was significantly higher than Group B(P=0.004).2 After one year follow-up the complete remission rates of the three groups were:72.00%(18/25),64.71%(11/17)and 100%(20/20),with a statistically significant difference(P=0.021).A significant difference between Group A,Group C and Group B,(P=0.011;P=0.004).The complete remission rates of Group C was the highest among the three groups.3 The recurrent rate after 1years was 20.00%(5/25)in Group A,0%(0/17)in Group B and 0%(0/20)in Group C.Conclusions 1 Compound Gosspol Acetate Tablets may be a better treatment for patients older than 45 years old.2 Goserelin acetate had better short-term effect,but the recurrent rate was higher than the other two methods in the treatment of mild atypical endometrial hyperplasia.
出处 《中国妇产科临床杂志》 CSCD 北大核心 2016年第1期31-33,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 子宫内膜轻度不典型增生 醋酸戈舍瑞林 醋酸甲羟孕酮 复方醋酸棉酚片 mild atypical endometrial hyperplasia acetate Goserelin acetate medroxyprogesterone acetate Compound Gosspol Acetate Tablets
  • 相关文献

参考文献11

  • 1榭幸,苟文丽,林仲秋,等.妇产科学.8版.北京:人民卫生出版社,2013:345-345.
  • 2Daud S, Jalil S, Griffin M, et al. Endometrial hyperplasia- the dilemma of management remains: a retrospective obser- vation study of 280 women. European Journal of Obsterics ga Gynecology and Reproductive Biology, 2011, 159: 172 - 175.
  • 3Fulda S. Modulation of apoptosis by natural products for cancer therapy. Planta Med, 2010, 76.. 1075 - 1079.
  • 4黄燕.醋酸棉酚片治疗子宫肌瘤的120例临床分析.医药前沿,2013,5:141-142.
  • 5张秀娟.醋酸棉酚联合米非司酮治疗功能性子宫出血的疗效观察[J].北方药学,2014,11(12):86-87. 被引量:5
  • 6龚庆琳,陈晓端,谢幸.保留生育功能治疗效果中的作用[J].中华妇产科杂志,2014,49(9):664-669. 被引量:6
  • 7Goncharenko VM, Beniuk VA, Kalenska OV, et al. Pre- dictive diagnosis of endometrial hyperplasia and personalized therapeutic strategy in women of fertile age. EPMA J, 2013, 4 24- 24.
  • 8Baker J, Obermair AV, Gebski V, et, al. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endome- trial adenocarcinoma: a meta-analysis and systematic review of the literature. Gynecol Oncol, 2012, 125:263 - 270.
  • 9Gallos ID, Yap J, Rajkhowa M, et al. Regression, re- lapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyper plasia: a systematic review and metaanalysis. Am J Obstet Gynecol, 2012, 207: 266-266.
  • 10Shan WW, Wang C, Zhang ZB, et al. Conservative therapy with metformin plus megestrol acetate for endometrial atypi- cal hyperplasia. J GynecolOncol, 2014, 25: 214-220.

二级参考文献19

  • 1刘冬娥.女性围绝经期的生理和病理变化[J].中国实用妇科与产科杂志,2004,20(8):473-474. 被引量:248
  • 2杨越波,李小毛,向阳.子宫肿瘤[M].北京:人民军医出版社,2011:193.
  • 3Ushijima K,Yahata H,Yoshikawa H,et al.Multicenter phase Ⅱ study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women[J].J Clin Oncol,2007,25:2798-2803.
  • 4Soliman PT,Oh JC,Schmeler KM,et al.Risk factors for young premenopausal women with endometrial cancer[J].Obstet Gynecol,2005,105:575-580.
  • 5Zaino R J,Kauderer J,Trimble CL,et al.Reproducibility of the diagnosis of atypical endometrial hyperplasia:a Gynecologic Oncology Group study[J].Cancer,2006,106:804-811.
  • 6Gunderson CC,Fader AN,Carson KA,et al.Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma:a systematic review[J].Gynecol Oncol,2012,125:477-482.
  • 7Zuckerman B,Lavie O,Neumann M,et al.Endometrial carcinoma stage Ⅰ-grade Ⅱ.Conservative treatment followed by a healthy twin pregnancy[J].Int J Gynecol Cancer,1998,8:172-174.
  • 8Lin MC,Lomo L,Baak JP,et al.Squamous morules are functionally inert elements of premalignant endometrial neoplasia[J].Mod Pathol,2009,22:167-174.
  • 9Makishi S,Kinjo T,Sawada S,et al.Morules and morule-like features associated with carcinomas in various organs:report with immunohistochemical and molecular studies[J].J Clin Pathol,2006,59:95-100.
  • 10Blanco LZ Jr,Heagley DE,Lee JC,et al.Immunohistochemical characterization of squamous differentiation and morular metaplasia in uterine endometrioid adenocarcinoma[J].Int J Gynecol Pathol,2013,32:283-292.

共引文献9

同被引文献47

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部